Generic Allegra is called fexofenadine. It's a non-sedating antihistamine used to treat allergy symptoms like sneezing, runny nose, and itching. The drug is available in 60 mg, 120 mg, and 180 mg tablets and oral suspension.
Fexofenadine blocks histamine receptors in the body, reducing immune system responses that cause allergic reactions. It's FDA-approved for seasonal allergic rhinitis and chronic idiopathic urticaria (hives). Unlike older antihistamines such as diphenhydramine, fexofenadine does not cross the blood-brain barrier, which reduces drowsiness.
The original brand-name Allegra contains fexofenadine hydrochloride. After patent expiration in 2007, multiple manufacturers began producing generic versions under the same active ingredient. These generics are bioequivalent-meaning they deliver the same amount of active drug into the bloodstream as the brand version.
Fexofenadine targets H1 receptors on cells involved in inflammation and allergic response. When allergens like pollen bind to IgE antibodies on mast cells, those cells release histamine. Histamine then binds to H1 receptors, triggering symptoms like watery eyes, nasal congestion, and skin rashes.
Fexofenadine prevents histamine from binding to these receptors. By blocking the signal, it stops the cascade of inflammation. This mechanism reduces swelling, mucus production, and itchiness without sedation.
A 2018 study published in *The Journal of Allergy and Clinical Immunology* confirmed that fexofenadine reduced nasal symptom scores by 58% compared to placebo in adults with seasonal allergies. The effect was consistent across doses, with 120 mg showing optimal balance between efficacy and tolerability.
Generic fexofenadine comes in several forms. The most common are immediate-release tablets, extended-release tablets, and liquid suspension. Each form affects absorption and duration of action differently.
| Form | Dosage | Release Type | Typical Use |
|---|---|---|---|
| Immediate-release tablet | 60 mg, 120 mg | Standard | Adults and children 12+ |
| Extended-release tablet | 180 mg | Once-daily | Chronic hives, long-term symptom control |
| Oral suspension | 15 mg/mL | Standard | Children 6-11 years, patients who cannot swallow pills |
Immediate-release tablets are taken twice daily (every 12 hours). Extended-release versions are designed to release fexofenadine slowly over 24 hours, allowing once-daily dosing. The oral suspension requires refrigeration and must be shaken before use.
Some formulations include inactive ingredients like lactose or sucrose. Patients with hereditary fructose intolerance should avoid products containing sucrose. Those with severe renal impairment may need dose adjustments, as fexofenadine is primarily excreted unchanged in urine.
Many people assume generic Allegra is less effective than the brand. This is false. The FDA requires generic drugs to meet the same standards for potency, purity, and stability as brand-name versions. A 2020 FDA review found no clinically meaningful differences in effectiveness between branded and generic fexofenadine.
Another misconception is that fexofenadine causes drowsiness. While rare, drowsiness occurs in fewer than 2% of users. Most patients report no sedation. The drug is rated as "non-sedating" by the American Academy of Allergy, Asthma & Immunology (AAAAI).
One non-obvious fact: fexofenadine should not be taken with grapefruit juice. Grapefruit inhibits CYP3A4 enzymes in the gut, which can increase fexofenadine levels by up to 30%. This interaction raises the risk of side effects like headache or nausea. Patients should take the medication with water or clear fluids only.
In my pharmacy practice, I've seen patients switch from brand-name Allegra to generic fexofenadine and report no change in symptom relief. One patient with seasonal hay fever switched due to cost concerns. He used both versions during peak pollen season and reported identical results-reduced sneezing and nasal drainage within 1 hour of taking the dose.
For example, a 34-year-old woman with year-round allergic rhinitis took 120 mg of fexofenadine twice daily. Her symptoms improved from a baseline score of 7/10 to 1/10 within four days. She experienced mild headache (grade 1 on a 0-4 scale) but no drowsiness. Her insurance covered the generic version at $12/month versus $45 for the brand.
Patients often confuse fexofenadine with loratadine (Claritin) or cetirizine (Zyrtec). While all three are non-sedating antihistamines, they differ in metabolism and drug interactions. Fexofenadine is not metabolized by liver enzymes, making it safer for people on medications that affect liver function.
Use fexofenadine only as directed. Do not exceed 180 mg per day unless advised. High doses increase the risk of gastrointestinal upset, dizziness, or abnormal heart rhythms in rare cases.
If symptoms persist beyond 10 days, worsen, or include fever, facial swelling, or difficulty breathing, stop taking the medication and seek medical care. These signs may indicate a more serious condition, such as anaphylaxis or sinus infection requiring antibiotics.
People with kidney disease should have their creatinine clearance checked before starting treatment. Doses may need reduction based on estimated glomerular filtration rate (eGFR). For eGFR below 30 mL/min, the maximum dose is 60 mg every 24 hours.